SmartTRAK, the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies, was cited as a source in 3M's presentation "3M to Acquire Acelity Inc." published on May 2.
In that 10-page presentation, SmartTRAK, along with the Brookings Institute, the International Diabetes Foundation and WHO, was cited as a source for statistical growth numbers in the Advanced Wound Care market, an $8B+ segment growing at 4-6% annually, with trends such as the rise of obesity, growth incidence of diabetes, an aging population and the fact that a rising middle class has better access to a higher level of care contributing to the favorable growth outlook in this large and expanding segment.
3M gave its strategic rational, saying that the acquisition of Acelity, a leading global medical technology company focused on the growing advanced wound care market and a pioneer in Negative Wound Pressure Therapy (NPWT), will contribute complementary products and technologies and a talented and innovative team that will support growth strategy, offering comprehensive advanced and surgical would care solutions to improve outcomes and enhance the patient and provider experience.
________________________________________________
SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click the button below.